InChI=1S/C32H43NO5/c1- 18(2) 13- 16- 36- 28(3,4) 26- 24(34) 27- 32(38- 27) 23(37- 26) 12- 14- 29(5) 30(6) 19(11- 15- 31(29,32) 35) 17- 21- 20- 9- 7- 8- 10- 22(20) 33- 25(21) 30/h7- 10,13,19,23- 24,26- 27,33- 35H,11- 12,14- 17H2,1- 6H3/t19- ,23- ,24+,26- ,27+,29+,30+,31- ,32- /m0/s1 |
GLVMTITYOKYZRQ-JSVBYLJXSA-N |
[H] [C@@] 12CC[C@] 3(O) [C@] (C) (CC[C@] 4([H] ) O[C@@H] ([C@@H] (O) [C@@] 5([H] ) O[C@@] 345) C(C) (C) OCC=C(C) C) [C@@] 1(C) c1[nH] c3ccccc3c1C2 |
|
Albophoma yamanashiensis
(IF:412380)
|
See:
PubMed
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
EC 2.3.1.26 (sterol O-acyltransferase) inhibitor
An EC 2.3.1.* (acyltransferase transferring other than amino-acyl group) inhibitor that interferes with the action of acyl-CoA:cholesterol acyltransferase (EC 2.3.1.26).
|
|
(2S,3R,3aR,4aS,4bS,6aS,12bS,12cR,14aS)- 12b,12c- dimethyl- 2- {2- [(3- methylbut- 2- en- 1- yl)oxy]propan- 2- yl}- 3,3a,5,6,6a,7,12,12b,12c,13,14,14a- dodecahydro- 2H,4bH- oxireno[4',4a']chromeno[5',6':6,7]indeno[1,2- b]indole- 3,4b- diol
|